Abstract
- Population : Immunocompetent individuals living in JE-endemic areas
- Intervention: One dose of live recombinant JE vaccine administered ≥ 12 months previously
- Comparison: Placebo/no vaccination/other JE vaccine
- Outcome : JE disease (immunogenicity accepted)
- GRADE table
- Japanese encephalitis
